Acadia Pharma (ACAD) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $27.29 -0.58%
Revenue Growth %: +19.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +19.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
